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MiR-138 Inhibits Tumor Growth Through Repression of EZH2 in Non-Small Cell Lung Cancer
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Introduction
Non-small cell lung cancer (NSCLC) including denocarcinomas, squamous cell carcinomas (SCC), and large cell carcinomas [1] , is the most common cancer worldwide and accounts for approximately 80% of the total lung cancer cases [2] . Although recent advances in clinical diagnosis and therapeutic strategies, the overall prognosis for patients with NSCLC remains poor, with a 5-year overall survival rate of approximately 11% [3] . Further understanding of the mechanisms of lung cancer development and progression is essential for improving the diagnosis, prevention and treatment of this disease.
MicroRNAs (miRNAs) are a class of endogenous small non-coding RNAs that repress gene expression by base pairing with messenger RNA (mRNA), leading to mRNA decay or translational repression [4] [5] [6] . Accumulating evidences have demonstrated that dysregulation of miRNAs may lead to alterations in diverse biological processes, such as proliferation, differentiation and apoptosis that are important in the development of cancer [7, 8] . Several deregulated miRNAs, inculding miR-126, miR-21, miR-200c, miR-145, miR-107, miR-185 and miR-101, have been shown to regulate NSCLC cell growth, apoptosis, migration and/or 138 [15] . It has been shown that ectopic expression of miR-138 in hepatocellular carcinoma inhibits cell growth [16] . Liu and colleagues [17] reported that miR-138 could suppress invasion and promote apoptosis in head and neck squamous cell carcinoma cell lines. These data indicate a potential tumour suppressive function of miR-138. However, the role and the molecular mechanisms of miR-138 in NSCLC remain largely unknown.
tissues and cell lines. Overexpression of miR-138 in NSCLC cells inhibited cell growth in vitro and tumor growth in nude mice. Furthermore, we showed that EZH2 was a direct functional of NSCLC.
Materials and Methods
Tissue samples and cell lines 18 human NSCLC tissue samples and matched normal lung tissues were collected from Shanghai Pulmonary Hospital. Tissues were immediately snap-frozen in liquid nitrogen after surgery and stored at human tissues was approved by Shanghai Pulmonal Hospital Ethical Committee. NSCLC cell lines A549, SPC-A1 (adenocarcinomas), SK-MES-1 (squamous carcinoma), H460 (large cell carcinoma) and normal human bronchial epithelial cell line (16HBE) were purchased from the Institute of Biochemistry and Cell Biology of the Chinese Academy of Sciences (Shanghai, China) and cultured in RPMI-1640 supplemented with 5 % CO 2 .
Total RNA isolation and quantitative real-time PCR (qRT-PCR)
Total RNA was extracted using TRIzol Reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions. For analysis of mature miR-138 expression, total RNA was reversely transcribed using TaqMan MicroRNA Reverse Transcription Kit (Applied Biosystems, Foster City, CA, USA)
For the detection of EZH2 mRNA, reverse transcription and qRT-PCR were performed using SYBR Green 2 analysis method. Experiments were performed in triplicate.
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Lentivirus production and infection
The pre-miR-138, EZH2 siRNA sequences or the coding sequences of EZH2 were cloned into pCDH-CMV-MCS-EF1-coGFP vectors (System Biosciences, California, USA). The primers for pre-miR-138 were:
were performed according to standard protocols as recommended by the manufacturer. A549 and H460 cells ( 1×10 5 ) were infected with 1×10 7 (Sigma, St Louis, Missouri, USA).
Plasmid construction and luciferase reporter assay
corresponding mutant constructs were created by site-directed mutagenesis (QuikChange, Stratagene, and H460 cells were cultured in 24-well plates and cotransfected with 200 ng of the luciferase reporter constructs and 20 ng of the pRL-CMV renilla luciferase reporter construct in the presence of either miR-138 or miR-control. After 48 h, luciferase activity was measured using the dual luciferase reporter assay system Cell proliferation, apoptosis and cell cycle analysis Cell proliferation was monitored using Cell Proliferation Reagent Kit I (MTT) (Roche Applied Science).
proliferation was documented every 24 h following the manufacturer's protocol. The resulting absorbance at 570 nm was measured on a spectrophotometer. For analysis of apoptosis, cells were stained with FITCequipped with a CellQuest software (BD Biosciences). For cell-cycle analysis, cells were suspended and stained with PI. Cell cycle assay was performed using an Epics Altra Flow Cytometer (BECKMAN Coulter, USA) and analyzed using EXPO32 Multicomp and EXPO32 v1.2 Analysis (BECKMAN Coulter, USA) software. All of the assays were conducted in triplicate.
Western blotting
Protein lysates were separated by 10% SDS-PAGE and then transferred to nitrocellulose membranes using enhanced chemiluminescence reagent. The expression level of EZH2 protein was normalized to that
Tumorigenicity assays in nude mice
Male BALB/c nude mice aged 5 to 6 weeks were purchased from Shanghai Experimental Animal Center (Shanghai, China). Animal handling and experimental procedures were approved by the Animal Experiments Ethics Committee of Tongji University. For tumor growth assay, miR-138-overexpressed A549 cells (1×10 6 weighed. Tumor volumes were calculated according to the following formula: Volume = (A×B 2 )/2, where A is the largest diameter and B is the shortest diameter.
Statistical analysis
Data are presented as mean ± SD of at least 3 independent experiments. Differences between groups were evaluated by SPSS 13.0 statistical software with Student's t-test when comparing only two groups or
Results
miR-138 is downregulated in NSCLC tissues and cell lines
to measure miR-138 expression levels in 18 NSCLC tissue samples and 4 NSCLC cell lines. As shown in Fig. 1A , the expression levels of miR-138 were downregulated in NSCLC tissues as compared to matched normal tissues from the same patients. The expression of miR-138 epithelial cell line (16HBE) (Fig. 1B) . These results suggested that downregulation of miR-138 might contribute to NSCLC carcinogenesis.
Overexpression of miR-138 suppresses proliferation, induces apoptosis and blocks G1/S transition in NSCLC cells
lines with stable overexpression of miR-138 by infecting A549 and H460 cells with lentivirus these established cell lines (Fig. 2A) . These cells were then used to determine their growth curve, apoptosis and cell-cycle distribution. As shown in Fig. 2B , the growth curve showed as compared to negative control cells. Furthermore, miR-138 overexpression provoked a robust apoptotic response in NSCLC cells determined by FACS (Fig. 2C) . Consistent with these observations, miR-138 overexpression enhanced the proportion of cells in G0/G1 phase, and decreased the number of cells in S phase in both A549 and H460 cells (Fig. 2D) . Taken together, our results indicate that miR-138 suppressed cell growth by inducing apoptosis and G0/G1 arrest in NSCLC cells.
EZH2 is a direct target of miR-138
To explore the molecular mechanism of miR-138, we adopted bioinformatic algorithms (TargetScan and PicTar) to predict a large number of potential miR-138 target genes. and this putative target site is highly conserved among the vertebrates. To verify whether 
Discussion
the molecular mechanisms by which miRNAs regulate the processes of diverse cancers are still unclear [18, 19] . Recently, Tan et al showed that the expression of miR-138 was decreased in SCC by microRNA microarray analysis [15] , but no data are available about its functions in NSCLC. In the present study, we investigated the potential suppressive roles and the mechanisms of miR-138 in the development and progression of NSCLC through cell models and tissue samples.
Previous studies have indicated that miR-138 plays critical roles in tumorigenesis. For instance, a decreased aberrant miR-138 expression is associated with enhanced cell proliferation and invasion in OSCC [17, 20] . Ectopic transfection of miR-138 in TSCC cells reduced the expression of GNAI2, which led to reduced proliferation, cell cycle arrest and apoptosis [21] . It was also observed that miR-138 may function as a nasopharyngeal carcinoma (NPC) suppressor by inhibiting CCND1 expression [22] . However, the functions of miR-138 in NSCLC is little known. To reveal the role of miR-138 in NSCLC, we tested the effect affected cell biological behaviors, that is, suppressing cell proliferation, enhancing apoptosis and inducing G0/G1 cell-cycle arrest. Furthermore, we found that stable overexpression of suggest that miR-138 functions as a tumor suppressor in NSCLC.
To explore the molecular mechanisms of miR-138-induced growth inhibition on NSCLC progression, we used bioinformatic algorithms to predict gene targets for miR-138. Although many cancer-associated genes were predicted, Enhancer of zeste homolog 2 (EZH2) was selected as a candidate target of miR-138 for further research because of its promoting role in the initiation and propagation of a number of cancers, including prostate, bladder, gastric, In summary, our results identify that miR-138 as a potential tumor suppressor could inhibit cell proliferation, induce cell apoptosis and G0/G1 cell-cycle arrest, by targeting EZH2 in NSCLC cells. Our data suggest that miR-138 could be employed as a potential therapeutic target for miRNA-based NSCLC therapy.
